131 related articles for article (PubMed ID: 12527400)
1. No association between polymorphisms in the neprilysin promoter region and Swedish Alzheimer's disease patients.
Lilius L; Forsell C; Axelman K; Winblad B; Graff C; Tjernberg L
Neurosci Lett; 2003 Feb; 337(2):111-3. PubMed ID: 12527400
[TBL] [Abstract][Full Text] [Related]
2. Association of the Neprilysin gene with susceptibility to late-onset Alzheimer's disease.
Sakai A; Ujike H; Nakata K; Takehisa Y; Imamura T; Uchida N; Kanzaki A; Yamamoto M; Fujisawa Y; Okumura K; Kuroda S
Dement Geriatr Cogn Disord; 2004; 17(3):164-9. PubMed ID: 14739539
[TBL] [Abstract][Full Text] [Related]
3. Dinucleotide repeat polymorphisms in the neprilysin gene are not associated with sporadic Alzheimer's disease.
Oda M; Morino H; Maruyama H; Terasawa H; Izumi Y; Torii T; Sasaki K; Nakamura S; Kawakami H
Neurosci Lett; 2002 Mar; 320(1-2):105-7. PubMed ID: 11849775
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in neprilysin gene affect the risk of Alzheimer's disease in Finnish patients.
Helisalmi S; Hiltunen M; Vepsäläinen S; Iivonen S; Mannermaa A; Lehtovirta M; Koivisto AM; Alafuzoff I; Soininen H
J Neurol Neurosurg Psychiatry; 2004 Dec; 75(12):1746-8. PubMed ID: 15548496
[TBL] [Abstract][Full Text] [Related]
5. Lack of association of neprilysin gene polymorphisms with Alzheimer's disease in a southern Chinese community.
Fu Y; Li AF; Shi JJ; Tang MN; Guo YB; Zhao ZH
Int Psychogeriatr; 2009 Apr; 21(2):354-8. PubMed ID: 19250583
[TBL] [Abstract][Full Text] [Related]
6. Neprilysin deficiency alters the neuropathological and behavioral phenotype in the 5XFAD mouse model of Alzheimer's disease.
Hüttenrauch M; Baches S; Gerth J; Bayer TA; Weggen S; Wirths O
J Alzheimers Dis; 2015; 44(4):1291-302. PubMed ID: 25408216
[TBL] [Abstract][Full Text] [Related]
7. Association between neprilysin polymorphisms and sporadic Alzheimer's disease.
Wood LS; Pickering EH; McHale D; Dechairo BM
Neurosci Lett; 2007 Nov; 427(2):103-6. PubMed ID: 17928142
[TBL] [Abstract][Full Text] [Related]
8. DNA methylation level of the neprilysin promoter in Alzheimer's disease brains.
Nagata K; Mano T; Murayama S; Saido TC; Iwata A
Neurosci Lett; 2018 Mar; 670():8-13. PubMed ID: 29339171
[TBL] [Abstract][Full Text] [Related]
9. Mutation screening and association study of the neprilysin gene in sporadic Alzheimer's disease in Chinese persons.
Shi J; Zhang S; Tang M; Ma C; Zhao J; Li T; Liu X; Sun Y; Guo Y; Han H; Ma Y; Zhao Z
J Gerontol A Biol Sci Med Sci; 2005 Mar; 60(3):301-6. PubMed ID: 15860464
[TBL] [Abstract][Full Text] [Related]
10. The Association between Neprilysin gene polymorphisms and Alzheimer's disease in Tibetan population.
Chen S; Mima D; Jin H; Dan Q; Wang F; Cai J; Shi L; Wang H; Du A; Tang Y; Sun Y
Brain Behav; 2021 Mar; 11(3):e02002. PubMed ID: 33314757
[TBL] [Abstract][Full Text] [Related]
11. Impact of Insulin Degrading Enzyme and Neprilysin in Alzheimer's Disease Biology: Characterization of Putative Cognates for Therapeutic Applications.
Jha NK; Jha SK; Kumar D; Kejriwal N; Sharma R; Ambasta RK; Kumar P
J Alzheimers Dis; 2015; 48(4):891-917. PubMed ID: 26444774
[TBL] [Abstract][Full Text] [Related]
12. Neprilysin Confers Genetic Susceptibility to Alzheimer's Disease in Han Chinese.
Wang HZ; Bi R; Zhang DF; Li GD; Ma XH; Fang Y; Li T; Zhang C; Yao YG
Mol Neurobiol; 2016 Sep; 53(7):4883-92. PubMed ID: 26362309
[TBL] [Abstract][Full Text] [Related]
13. Recombinant soluble neprilysin reduces amyloid-beta accumulation and improves memory impairment in Alzheimer's disease mice.
Park MH; Lee JK; Choi S; Ahn J; Jin HK; Park JS; Bae JS
Brain Res; 2013 Sep; 1529():113-24. PubMed ID: 23831521
[TBL] [Abstract][Full Text] [Related]
14. NEP-like endopeptidases and Alzheimer's disease [corrected].
Marr RA; Spencer BJ
Curr Alzheimer Res; 2010 May; 7(3):223-9. PubMed ID: 20088804
[TBL] [Abstract][Full Text] [Related]
15. Oxidized neprilysin in aging and Alzheimer's disease brains.
Wang DS; Iwata N; Hama E; Saido TC; Dickson DW
Biochem Biophys Res Commun; 2003 Oct; 310(1):236-41. PubMed ID: 14511676
[TBL] [Abstract][Full Text] [Related]
16. [Elucidating Pathogenic Mechanisms of Early-onset Alzheimer's Disease in Down Syndrome Patients].
Asai M; Kawakubo T; Mori R; Iwata N
Yakugaku Zasshi; 2017; 137(7):801-805. PubMed ID: 28674290
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis of expression and function of neprilysin in Alzheimer's disease.
Zhang H; Liu D; Wang Y; Huang H; Zhao Y; Zhou H
Neurosci Lett; 2017 Sep; 657():69-76. PubMed ID: 28778804
[TBL] [Abstract][Full Text] [Related]
18. Combined risk effects of IDE and NEP gene variants on Alzheimer disease.
Vepsäläinen S; Helisalmi S; Mannermaa A; Pirttilä T; Soininen H; Hiltunen M
J Neurol Neurosurg Psychiatry; 2009 Nov; 80(11):1268-70. PubMed ID: 19864659
[TBL] [Abstract][Full Text] [Related]
19. Lack of association of neprilysin polymorphism with Alzheimer's disease and Alzheimer's disease-type neuropathological changes.
Sodeyama N; Mizusawa H; Yamada M; Itoh Y; Otomo E; Matsushita M
J Neurol Neurosurg Psychiatry; 2001 Dec; 71(6):817-8. PubMed ID: 11762318
[No Abstract] [Full Text] [Related]
20. Neprilysin gene transfer: A promising therapeutic approach for Alzheimer's disease.
Li Y; Wang J; Zhang S; Liu Z
J Neurosci Res; 2015 Sep; 93(9):1325-9. PubMed ID: 26096375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
